Clinical trials
Genetic Diseases, Inborn trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioMarin Pharmaceutical | 3 |
| PTC Therapeutics | 3 |
| Genzyme, a Sanofi Company | 2 |
| Hacettepe University | 2 |
| Istanbul University | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Forma Therapeutics, Inc. | 1 |
| GenEmbryomics Pty. Ltd | 1 |
| Hitit University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Diseases, Inborn | 24 |
| Musculoskeletal Diseases | 8 |
| Genetic Diseases, X-Linked | 5 |
| Metabolic Diseases | 5 |
| Nervous System Diseases | 5 |
| Hematologic Diseases | 4 |
| Lysosomal Storage Diseases | 4 |
| Metabolism, Inborn Errors | 4 |
| Blood Coagulation Disorders | 3 |
| Blood Coagulation Disorders, Inherited | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.